Suchergebnisse - "Polonini, Hudson"

PubPharm (76)

41

Suspensions as a Valuable Alternative to Extemporaneously Compounded Capsules

enthalten in: International journal of pharmaceutical compounding | 2017

von Dijkers, E. | Nanhekhan, V. | Thorissen, A. | +1

42

Ex vivo Skin Permeation Evaluation of An Innovative Transdermal Vehicle Using Nimesulide and Piroxicam as Model Drugs

enthalten in: Current drug delivery | 2017

von Pereira, R. | Pelisson E Silva, T. | de Oliveira Ferreira, A. | +3

43

Transdermal Oxandrolone : Ex Vivo Percutaneous Absorption Study

enthalten in: Current drug delivery | 2017

von Polonini, H. | de Oliveira Ferreira, A. | Raposo, N. | +1

44

Ex vivo Skin Permeation Evaluation of An Innovative Transdermal Vehicle Using Nimesulide and Piroxicam as Model Drugs

enthalten in: Current drug delivery | 2017

von Pereira, R. | Silva, T. | Ferreira, A. | +3

45

Transdermal Oxandrolone: Ex Vivo Percutaneous Absorption Study

enthalten in: Current drug delivery | 2017

von Polonini, H. | de Oliveira Ferreira, A. | Rezende Barbosa Raposo, N. | +1

46

Compatibility of caffeine, carvedilol, clomipramine hydrochloride, folic acid, hydrochlorothiazide, loperamide hydrochloride, methotrexate, nadolol, naltrexone hydrochloride and pentoxifylline in SyrSpend SF PH4 oral suspensions

enthalten in: European journal of hospital pharmacy : science and practice | 2016

von Polonini, H. | Silva, S. | de Almeida, T. | +2

47

Stability of Allopurinol, Amitriptyline Hydrochloride, Carbamazepine, Domperidone, Isoniazid, Ketoconazole, Lisinopril, Naproxen, Paracetamol (Acetaminophen), and Sertraline Hydrochloride in SyrSpend SF PH4 Oral Suspensions

enthalten in: International journal of pharmaceutical compounding | 2016

von Polonini, H. | Loures, S. | de Araujo, E. | +2

48

Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions

enthalten in: International journal of pharmaceutical compounding | 2016

von Polonini, H. | Loures, S. | Lima, L. | +2

49

Feasibility of amlodipine besylate, chloroquine phosphate, dapsone, phenytoin, pyridoxine hydrochloride, sulfadiazine, sulfasalazine, tetracycline hydrochloride, trimethoprim and zonisamide in SyrSpend(®) SF PH4 oral suspensions

enthalten in: Journal of pharmaceutical and biomedical analysis | 2016

von Ferreira, A. | Polonini, H. | Silva, S. | +3

50

Feasibility of amlodipine besylate, chloroquine phosphate, dapsone, phenytoin, pyridoxine hydrochloride, sulfadiazine, sulfasalazine, tetracycline hydrochloride, trimethoprim and zonisamide in SyrSpend(®) SF PH4 oral suspensions

enthalten in: Journal of pharmaceutical and biomedical analysis | 2016

von Ferreira, A. | Polonini, H. | Silva, S. | +3